Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

A Study of Multiple-ascending Doses of GSBR-1290 in Healthy Overweight/Obese Participants

Gasherbrum Bio, Inc · Phase 1 · Status n/r · Enrollment 70

NCT06139055

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Part 1 (Sequence 1: Capsule to Tablet): GSBR-1290 Capsule/GSBR-1290 Tabletn/rn/rn/rn/rn/r
Part 1(Sequence 2: Tablet to Capsule): GSBR-1290 Tablet/GSBR-1290 Capsulen/rn/rn/rn/rn/r
Part 2 (Cohort 1): GSBR-1290/Placebo Tabletn/rn/rn/rn/rn/r
Part 2 (Cohort 2): GSBR-1290/Placebo Tabletn/rn/rn/rn/rn/r
Part 2 (Cohort 3): GSBR-1290/Placebo Tablet and GSBR-1290/Placebo Capsulen/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.